1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • AIDS malignancy consortium (AMC) study 061: A phase I/PK study of sunitinib (S) with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors
    Meeting Abstract

    Deeken, J. F.; Rudek, M. A.; Aboulafia, D. M.; Sullivan, R. J.; Gerecitano, J. F.; Cianfrocca, M. E.; Henry, D. H.; Ratner, L.; Dezube, B. J.; Mosby, K.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Pathogeneses of noninflammatory locally advanced breast cancer
    Meeting Abstract

    Dahi, P. B.; Axiotis, C. A.; Dhiran, K.; Weedon, J.; El-Tamer, M.; Braverman, A. S.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Immunogenicity of GI-4000 vaccine in adjuvant consolidation therapy following definitive treatment in patients with stage I-III adenocarcinoma of the lung with G12C, G12D, or G12V KRAS mutations
    Meeting Abstract

    D'Angelo, S. P.; Park, B. J.; Krug, L. M.; Crevar, C.; Medina, C. E.; Sumner, D. K.; Richman, J.; Coeshott, C.; Apelian, D.; Cohn, A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • FDG-PET in the staging and prognosis of T-cell lymphoma
    Meeting Abstract

    Casulo, C.; Maragulia, J.; Zelenetz, A. D.; Schòˆder, H.; Feeney, J.; Horwitz, S. M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Safety, pharmacokinetics (PK), pharmacodynamics (PD), and clinical activity of the oral AKT inhibitor GSK2141795 (GSK795) in a phase I first-in-human study
    Meeting Abstract

    Burris, H. A.; Siu, L. L.; Infante, J. R.; Wheler, J. J.; Kurkjian, C.; Opalinska, J.; Smith, D. A.; Antal, J. M.; Gauvin, J. L.; Gonzalez, T.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Pharmacokinetics (PK) and pharmacodynamics (PD) of RG7112, an oral murine double minute 2 (MDM2) antagonist, in patients with leukemias and solid tumors
    Meeting Abstract

    Beryozkina, A.; Nichols, G. L.; Reckner, M.; Vassilev, L. T.; Rueger, R.; Jukofsky, L.; Middleton, S.; Andreeff, M.; Padmanabhan, S.; Strair, R.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Lymphodepletion and tumor burden govern clinical responses in patients with B-cell malignancies treated with autologous, CD19-targeted T cells
    Meeting Abstract

    Brentjens, R. J.; Riviere, I.; Park, J.; Davilla, M.; Wang, X.; Yeh, R.; Lamanna, N.; Frattini, M. G.; Sadelain, M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in patients (pts) with castration-resistant prostate cancer (CRPC): Preliminary results
    Meeting Abstract

    Slovin, S. F.; Kargman, M.; Durso, R.; Curley, T.; Israel, R. J.; Olson, W. C.; Morris, S.; Murphy, D.; Scher, H. I.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Effect of the novel anti-androgen ARN-509 on response and seizure in castration-resistant prostate cancer models
    Meeting Abstract

    Hager, J. H.; Smith, N. D.; Bischoff, E.; Jung, M. E.; Sawyers, C. L.; Heyman, R. A.; Rix, P. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Genomic analysis of circulating tumor cells to evaluate predictive biomarkers
    Meeting Abstract

    Danila, D. C.; Anand, A.; Yao, J.; Gierszewska, M.; Kramer, M.; Fleisher, M.; Sawyers, C. L.; McCombie, W. R.; Scher, H. I.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save